
Cancer vaccines represent a promising therapeutic approach for which prime time is zzso However, clinical efficacy must be improved in order for cancer vaccines to become a valid alternative or complement to traditional cancer zzso zzso efforts have been undertaken so far to better understand the fundamental requirements for zzso cancer zzso Recent data emphasize that important requirements, among others, are zzso the use of zzso zzso possibly zzso from different tumor zzso zzso the selection of effective zzso zzso the association of cancer vaccines with agents able to counteract the regulatory milieu present in the tumor zzso and zzso the need to choose the definitive zzso and regimen of a vaccine after accurate preliminary tests comparing different zzso zzso The first requirement deals with issues related to zzso restriction of tumor zzso zzso as well as usefulness of tumor zzso spreading and zzso of immune escape phenomena, linked to tumor zzso zzso for an effective zzso immune zzso The second point underscores the necessity of optimal zzso of innate immunity to achieve an efficient zzso zzso immune zzso The third point focuses on the importance to inhibit zzso of regulatory zzso The last requirement stresses the concept that the regimen and zzso of the vaccine impacts profoundly on cancer vaccine zzso A new generation of cancer vaccines, provided with both zzso and clinical zzso will hopefully soon address these zzso 

